Proxima
proxima.health
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$80M
1 round on record
Latest round
$80M
Venture round · Jan 2026 · 9 mo ago
Team
201-500
employees, estimated range
Backers
1
Long Journey Ventures
The money's age
Fresh money
9 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 14
Raised a round Venture round $80M · Pulse 2.0
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2026 | $80M | — | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Long Journey Ventures Investors in similar startupsfunds that back the companies most like this one
backs Million Marker
backs Origen-Air-Logo
Similar startupsby what they do, their industry and backers
AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous…
Shop healthy coffee for pure energy and focus. Explore our clean, toxin-free speciality coffee blends and mushroom coffees.
Million Marker reveals your exposure to fertility-disrupting toxins so you can make changes to improve your chances of conceiving.
At-home PFAS testing using state-of-the-art technology: Helping everyone live healthier lives in the face of toxin exposure in the…
Rivotto, an environmental technologies company, has a simple and affordable.
Origen Air’s state-of-the-art filtration technology and genetically enhanced plants work together to provide superior air purification…
Overview
+ The Science + Diagnostics + Interventions + Practitioners + About + + About Proxima Health + + Our mission is to enable people to live unburdened by environmental toxins. Environmental toxins are in all of us.
News
Proxima Fusion Raises €411 Million at a €2.4B Valuation to Build Europe's Commercial Fusion Champion
Read more
Report
Proxima: $80 Million Raised To Power The Next Generation Of Proximity-Based Medicines
Proxima, the AI-native biotech company developing drug discovery tools and therapeutics for proximity-based medicines, has raised an oversubscribed $80 million seed round and rebranded from VantAI as it sharpens its focus on proximity therapeutics. The fi
Read more
Report
Marketers Gain Enhanced Precision Through Proxima's Collaboration with Microsoft Curate for Commerce
NEW YORK, October 16, 2025--Proxima, a data intelligence platform that specializes in precision marketing, today announced that they are leveraging Microsoft Curate for Commerce to enable advertisers to target their social-first, first-party ecommerce tra
Read more
Report
Constraining Proxima b's Atmosphere, Orbit, and Albedo with RISTRETTO
What new methods can be employed to help astronomers distinguish the light from an exoplanet and its host star so the former's atmosphere can be better explored? This is what a recent study accepted to Astronomy & Astrophysics hopes to address as an inter
Read more
Report
Show more news
Financials
Total raised
$80M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $80M | Details |